LIAN - BofA downgrades LianBio to underperform cites pipeline optionality
2024-01-03 09:57:25 ET
More on LianBio
- Johnson & Johnson inks licensing deal with LianBio (update)
- LianBio confirms buyout offer from Concentra Biosciences
- Seeking Alpha’s Quant Rating on LianBio
- Historical earnings data for LianBio
- Financial information for LianBio
For further details see:
BofA downgrades LianBio to underperform, cites pipeline optionality